ORALB 521 - Medical Microbiology and Immunology Website
ORALB 520 - Molecular Microbiology and Oral Diseases Website
Publications
Darveau, R.P., McFall-Ngai, M., Ruby, E., Miller, S., and Mangan, D.F. Commensal bacteria: beneficial partners in human health and development. Feature Article, ASM News, April Issue, 2003.
Darveau, R.P., Arbabi, S., garcia, I., Bainbridge, B., and Maier, R.V. Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect Immun. 70:1867-73., 2002.
Roberts, F.A. and Darveau, R.P. Beneficial bacteria of the periodontium. Periodontol. 30:40-50, 2000.
Darveau, R.P., Belton, C.M., Reife, R.A., and Lamont, R.J. Local Chemokine Paralysis: A novel pathogenic mechanism for Porphyromonas. Infect. Immunity. 66:1660-1665, 1998.
Shapiro, R.A., Cunningham, M.D., Ratcliffe, K., Seachord, C., Blake, J., Bajorath, J., Aruffo, A. and Darveau, R.P. Identification of CD 14 residues involved in specific lipopolysaccharide recognition. Infect. Immun. 65:293-297, 1997.
Guo, L., Lim, K.B., Gunn, J.S., Bainbridge, B., Darveau, R.P., Hackett, M. and Miller, S.I. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science. 276:250-253, 1997.
Bainbridge, B.W., Page, R.C., and Darveau, R.P. Immune sera to Porphyromonas gingivalis block the mononuclear cell PGE2 response to lipopolysaccharide. Infect. Immunity. 65:4801-4805, 1997.